TipRanks
Advertisement
Advertisement

BMY Stock Latest News

Bristol Myers price target raised to $82 from $75 at Piper Sandler
The FlyBristol Myers price target raised to $82 from $75 at Piper Sandler
37m ago
BMY
BioMarin names Robert Plenge, M.D., Ph.D., to board of directors
PremiumThe Fly
BioMarin names Robert Plenge, M.D., Ph.D., to board of directors
2d ago
BMY
BMRN
Snowflake, Applied Materials, Dell, Zoom, Bristol-Myers Insider Shock
PremiumWeekend Updates
Snowflake, Applied Materials, Dell, Zoom, Bristol-Myers Insider Shock
4d ago
ZM
BMY
BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod
PremiumCompany Announcements
BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod
6d ago
BMY
Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors
6d ago
BMY
Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
PremiumCompany AnnouncementsBladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
6d ago
BMY
Bristol Myers price target raised to $65 from $60 at HSBC
Premium
The Fly
Bristol Myers price target raised to $65 from $60 at HSBC
6d ago
BMY
Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial
Premium
The Fly
Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial
8d ago
BMY
Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial
PremiumCompany Announcements
Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial
12d ago
BMY
Eikon Therapeutics appoints Ching-Pin Chang as chief scientific officer
PremiumThe Fly
Eikon Therapeutics appoints Ching-Pin Chang as chief scientific officer
13d ago
BMY
EIKN
Novartis halts autoimmune CAR-T trials following three deaths, Reuters says
PremiumThe Fly
Novartis halts autoimmune CAR-T trials following three deaths, Reuters says
15d ago
BMY
NVS
Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study
PremiumThe Fly
Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study
17d ago
BMY
Procter & Gamble, Target, Canopy, Bristol, Oklo Insider Shock
PremiumWeekend UpdatesProcter & Gamble, Target, Canopy, Bristol, Oklo Insider Shock
18d ago
PG
BMY
Bristol-Myers Squibb Extends Deucravacitinib Program, Signaling Long-Term Autoimmune Ambitions
Premium
Company Announcements
Bristol-Myers Squibb Extends Deucravacitinib Program, Signaling Long-Term Autoimmune Ambitions
20d ago
BMY
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
Premium
The Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
21d ago
AA
MT
Bristol Myers Squibb Stock (BMY) Looks Healthier After Ditching Blood Cancer Partner
PremiumMarket News
Bristol Myers Squibb Stock (BMY) Looks Healthier After Ditching Blood Cancer Partner
22d ago
BMY
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
22d ago
ABT
BMY
Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story
PremiumCompany Announcements
Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story
26d ago
BMY
Bristol‑Myers Squibb Advances Navlimetostat Metabolism Study, Signaling Steady Pipeline Progress
PremiumCompany Announcements
Bristol‑Myers Squibb Advances Navlimetostat Metabolism Study, Signaling Steady Pipeline Progress
27d ago
BMY
Bristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
PremiumRatingsBristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
27d ago
BMY
Bristol-Myers Squibb: Sell Rating Reiterated as Competitive Pressures Mount; $40 Price Target Unchanged Signaling Further Downside
Premium
Ratings
Bristol-Myers Squibb: Sell Rating Reiterated as Competitive Pressures Mount; $40 Price Target Unchanged Signaling Further Downside
30d ago
BMY
Atrium Therapeutics earns $15M milestone payment from Bristol Myers
Premium
The Fly
Atrium Therapeutics earns $15M milestone payment from Bristol Myers
1M ago
BMY
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >